Bayer AG
BET:BAYER
Relative Value
The Relative Value of one
BAYER
stock under the Base Case scenario is
hidden
HUF.
Compared to the current market price of 17 340 HUF,
Bayer AG
is
hidden
.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Multiples Across Competitors
BAYER Competitors Multiples
Bayer AG Competitors
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| DE |
|
Bayer AG
BET:BAYER
|
44.5B HUF | 1 | -224.8 | 11.4 | 36.3 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
1.1T USD | 17.7 | 57 | 38.2 | 41 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
564.7B USD | 6 | 21.1 | 14.7 | 18 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
287.9B CHF | 4.7 | 30.7 | 12.9 | 15.1 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
294.9B USD | 4.6 | 15.5 | 10.9 | 12.9 | |
| CH |
|
Novartis AG
SIX:NOVN
|
229.6B CHF | 5.3 | 20.5 | 12.9 | 16.6 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
215B GBP | 5.1 | 31.6 | 15.1 | 22.1 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
218B USD | 94 | -74.6 | 333.1 | 835.4 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.4T DKK | 4.3 | 13.1 | 9.2 | 10.6 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
153.2B USD | 2.4 | 15.6 | 7.8 | 10.7 | |
| FR |
|
Sanofi SA
PAR:SAN
|
98.9B EUR | 1.8 | 8.3 | 7.7 | 7.7 |